NDAORALTABLET
Approved
Oct 1963
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
RENESE-R is a fixed-dose combination oral tablet containing polythiazide (a thiazide diuretic) and reserpine (an antihypertensive alkaloid) approved in 1963 for hypertension management. The combination leverages dual mechanisms: polythiazide reduces blood volume and sodium reabsorption while reserpine depletes norepinephrine stores to lower blood pressure. This product represents a legacy antihypertensive from the pre-ACE inhibitor era.
LOE Approaching
Declining
With LOE approaching and minimal linked job activity, this legacy product likely operates within a very small commercial footprint with minimal sales team expansion opportunities.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on RENESE-R offers minimal career growth opportunity; the product is positioned in late lifecycle with zero linked job openings and declining competitive relevance. Career professionals on this brand are typically managing end-of-life compliance, historical data stewardship, or supporting legacy portfolio maintenance within larger pharmaceutical organizations.
Regulatory Affairs Specialist
Worked on RENESE-R at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.